MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 - Yahoo Finance
| MDXH Stock | USD 2.00 0.04 2.04% |
Under 52% of MDxHealth's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding MDxHealth SA ADR suggests that some traders are interested. MDxHealth's investing sentiment shows overall attitude of investors towards MDxHealth SA ADR.
MDxHealth |
MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 Yahoo Finance
Read at news.google.com
 |
MDxHealth Fundamental Analysis
We analyze MDxHealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MDxHealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MDxHealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
MDxHealth is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
MDxHealth SA ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MDxHealth stock to make a market-neutral strategy. Peer analysis of MDxHealth could also be used in its relative valuation, which is a method of valuing MDxHealth by comparing valuation metrics with similar companies.
Peers
MDxHealth Related Equities
| ELDN | Eledon Pharmaceuticals | 9.39 | ||||
| ELEV | Elevation Oncology | 3.23 | ||||
| DAWN | Day One | 1.53 | ||||
| ABOS | Acumen Pharmaceuticals | 0.44 | ||||
| INZY | Inozyme Pharma | 0.37 |
Complementary Tools for MDxHealth Stock analysis
When running MDxHealth's price analysis, check to measure MDxHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MDxHealth is operating at the current time. Most of MDxHealth's value examination focuses on studying past and present price action to predict the probability of MDxHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MDxHealth's price. Additionally, you may evaluate how the addition of MDxHealth to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |